
Tazorap 4000mg/500mg Injection
Marketer
Haustus Biotech Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazorap 4000mg/500mg Injection
Combiflox 4000mg/500mg injection is a dual-antibiotic formulation effective against a wide spectrum of bacterial infections. Its mechanism involves microbial eradication. Administration should always be by a qualified medical practitioner; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on the infection's severity. Adherence to the prescribed regimen is crucial. Commonly reported adverse effects encompass nausea, vomiting, diarrhea, and skin rashes. Injection site reactions, including pain, inflammation, or erythema, may also occur. Persistent or worsening side effects warrant immediate medical consultation. Prior to treatment, inform your doctor of any antibiotic allergies, hepatic, or renal dysfunction; dosage adjustments or alternative therapies may be necessary. While generally safe under medical guidance, its use during pregnancy and lactation should be closely monitored by a healthcare professional.
Primary Ingredients of Tazorap 4000mg/500mg Injection
No text was provided to rewrite.
Uses of Tazorap 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazorap 4000mg/500mg Injection:
Administering this medication will be handled by your physician or their associate; self-medication is strictly prohibited.
Common Side effects of Tazorap 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazorap 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Tazorap 4000mg/500mg Injection works:
The injectable formulation Tazorap 4000mg/500mg unites piperacillin, a bacterial cell wall synthesis inhibitor, with tazobactam, a beta-lactamase inhibitor. This synergistic combination combats bacterial infection by disrupting bacterial defenses and bolstering piperacillin's antimicrobial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Tazorap 4000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazorap, 4000mg/500mg, is typically deemed safe for use during gestation. Preclinical trials using animal models have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazorap, 4000mg/500mg, presents no known breastfeeding contraindications. Research in humans indicates negligible transfer to breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Tazorap 4000mg/500mg Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, the administration of Tazorap 4000mg/500mg Injection requires careful consideration. Dosage modification of Tazorap 4000mg/500mg Injection might be necessary. Medical advice should be sought.
LiverSAFE IF PRESCRIBED
The use of Tazorap 4000mg/500mg Injection in patients with hepatic impairment appears to pose minimal risk. Existing evidence indicates dose modification for Tazorap 4000mg/500mg Injection may be unnecessary in such cases. However, physician consultation is recommended.
What if you forget to take Tazorap 4000mg/500mg Injection :
Omit a Tazorap 4000mg/500mg Injection dose? Seek immediate medical advice.
Facts to Know About Tazorap 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
